Efficacy and safety of microfoam sclerotherapy in a patient with Klippel-Trenaunay syndrome and a patent foramen ovale

Archives of Dermatology

Volumn 145, Issue 10, 2009, Pages 1147-1151

  Redondo, Pedro ^a   Bastarrika, Gorka ^a   Sierra, Alejandro ^a   Martínez Cuesta, Antonio ^a   Cabrera, Juan ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

POLIDOCANOL;

ADULT; ANGIOOSTEOHYPERTROPHY SYNDROME; ARTICLE; CASE REPORT; COMPRESSION GARMENT; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MIDDLE CEREBRAL ARTERY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATENT FORAMEN OVALE; PHLEBOGRAPHY; PRIORITY JOURNAL; SCLEROTHERAPY; TREATMENT PLANNING; VARICOSIS; VEIN MALFORMATION; VENOUS CIRCULATION;

ABNORMALITIES, MULTIPLE; ADULT; FEMALE; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; HUMANS; INJECTIONS, INTRAVENOUS; KLIPPEL-TRENAUNAY-WEBER SYNDROME; PHLEBOGRAPHY; POLYETHYLENE GLYCOLS; RISK ASSESSMENT; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VARICOSE VEINS;

EID: 70350236918     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.210     Document Type: Article

References (37)

1. Klippel M, Trenaunay P. Du naevus variquex osteohypertrophique. Arch Gen Med (Paris). 1900;3:641-672.
2. Bastarrika G, Redondo P, Sierra A, et al. New techniques for the evaluation and therapeutic planning of patients with Klippel-Trenaunay syndrome. J Am Acad Dermatol. 2007;56(2):242-249. (Pubitemid 46074245)
3. Cabrera J, Cabrera J Jr, García-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol. 2003;139 (11):1409-1416. (Pubitemid 37433130)
4. Pascarella L, Bergan JJ, Yamada C, Mekenas L. Venous angiomata: treatment with sclerosant foam. Ann Vasc Surg. 2005;19(4):457-464. (Pubitemid 41126041)
5. McDonagh B, Sorenson S, Cohen A, et al. Management of venous malformations in Klippel-Trenaunay syndrome with ultrasound-guided foam sclerotherapy. Phlebology. 2005;20(2):63-81. (Pubitemid 40863371)
6. Nitecki S, Bass A. Ultrasound-guided foam sclerotherapy in patients with Klippel-Trenaunay syndrome. Isr Med Assoc J. 2007;9(2):72-75. (Pubitemid 46351244)
7. Cabrera J, Cabrera J Jr, inventors; BTG International Ltd, assignee. Injectable microfoam containing a sclerosing agent. European patent EP656203. June 21, 1993.
8. Cabrera J, Cabrera J Jr, inventors; BTG International Ltd, assignee. Injectable microfoam containing a sclerosing agent. US patent 5676962. October 16, 1997.
9. Paltiel HJ, Burrows PE, Kozakewich HP, Zurakowski D, Mulliken JB. Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology. 2000;214(3):747-754. (Pubitemid 30115375)
10. Burrows PE, Mulliken JB, Fellows KE, Strand RD. Childhood hemangiomas and vascular malformations: angiographic differentiation. AJRAmJ Roentgenol. 1983; 141(3):483-488.
11. Lee A, Driscoll D, Gloviczki P, Clay R, Shaughnessy W, Stans A. Evaluation and management of pain in patients with Klippel-Trenaunay syndrome: a review. Pediatrics. 2005;115(3):744-749. (Pubitemid 43373038)
12. Jacob AG, Driscoll DJ, Shaughnessy WJ, Stanson AW, Clay RP, Gloviczki P. Klippel-Trenaunay syndrome: spectrum and management. Mayo Clin Proc. 1998; 73(1):28-36.
13. Mazoyer E, Enjolras O, Laurian C, Houdart E, Drouet L. Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merrit syndrome. Clin Lab Haematol. 2002;24(4):243-251. (Pubitemid 34989256)
14. Huiras EE, Barnes CJ, Eichenfield LF, Pelech AN, Drolet BA. Pulmonary thromboembolism associated with Klippel-Trenaunay syndrome [published online ahead of print September 15, 2005]. Pediatrics. 2005;116(4):e596-e600.
15. de Lorimier AA. Sclerotherapy for venous malformations. J Pediatr Surg. 1995; 30(2):188-193, discussion 194.
16. Villavicencio JL. Primum non nocere: is it always true? the use of absolute ethanol in the management of congenital vascular malformations. J Vasc Surg. 2001; 33(4):904-906.
17. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound- guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg. 2008;47(3):578-584. (Pubitemid 351258277)
18. Wollmann JCGR. The history of sclerosing foams. Dermatol Surg. 2004;30(5):694-703, discussion 703.
19. Cabrera J, Cabrera J Jr, García-Olmedo MA. Elargissement des limites de la sclerotherapie: nouveaux produits sclerosants. Phlebologie. 1997;2(4):181-188.
20. Cabrera J, Cabrera J Jr, García-Olmedo MA. Treatment of varicose long saphenous veins with sclerosant in microfoam form: long-term outcomes. Phebology. 2000;15(1):19-23. (Pubitemid 30739995)
21. Eckmann DM, Kobayashi S, Li M. Microvascular embolization following polidocanol microfoam sclerosant administration. Dermatol Surg. 2005;31(6):636-643. (Pubitemid 43093414)
22. Bikerman JJ. Foams. New York, NY: Springer-Verlag; 1973.
23. Redondo P, Cabrera J. Microfoam sclerotherapy. Semin Cutan Med Surg. 2005; 24(4):175-183.
24. Barrett JM, Allen B, Ockelford A, Goldman MP. Microfoam ultrasound-guided sclerotherapy of varicose veins in 100 legs. Dermatol Surg. 2004;30(1):6-12. (Pubitemid 38174021)
25. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg. 2004;30(5):718-722. (Pubitemid 38657962)
26. Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases history and analysis of safety and complications. Dermatol Surg. 2002; 28(1):11-15. (Pubitemid 34101573)
27. Hsu TS, Weiss RA. Foam sclerotherapy: a new era. Arch Dermatol. 2003;139(11): 1494-1496.
28. Breu FX, Guggenbichler S. European consensus meeting on foam sclerotherapy, April 4-6, 2003, Tegernsee, Germany. Dermatol Surg. 2004;30(5): 709-717, discussion 717.
29. Regan JD, Gibson KD, Ferris B, et al. Safety of proprietary sclerosant microfoam for saphenous incompetence in patients with R-to-L shunt: interim report. J Vasc Interv Radiol. 2008;19(suppl 2):S35.
30. Kerns SR, Hawkins IF Jr. Carbon dioxide digital subtraction angiography: expanding applications and technical evolution. AJR Am J Roentgenol. 1995; 164(3):735-741.
31. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation. 2003;107(1):5-9. (Pubitemid 36070923)
32. Ceulen RPM, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med. 2008;358(14):1525-1526.
33. Passariello F. Sclerosing foam and patent foramen ovale: the final report. Int Angiol. 2007;26(suppl 1):87.
34. Guex JJ, Raymond-Martimbeau P, Simka M, Passariello F. Letter regarding article titled "Microembolism during foam sclerotherapy of varicose veins" in the New England Journal of Medicine. Phlebology. 2008;23(5):249-250.
35. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose veins foam injection sclerotherapy. J Vasc Surg. 2006;43(1):162-164. (Pubitemid 43083525)
36. Schaefer PW. Applications of DWI in clinical neurology. J Neurol Sci. 2001;186 (suppl 1):S25-S35.
37. Rush JE, Wright DDI. More on microembolism and foam sclerotherapy. N Engl J Med. 2008;359(6):656-657, author reply 657.